New Zealand diabetes breakthrough

A biotech company in New Zealand is pioneering a new type of diabetic treatment, using a pig cell transplant in order to help diabetic patients stop injecting insulin to manage their disease.
Living Cell Technologies (LCT), who are based in Auckland, conducted a trial of their procedure in Russia due to restrictions in New Zealand. According to the company, one of the two patients taking part in their Russian trial could potentially be cured of diabetes .
The inventor of the therapy, and the medical director of LCT, Professor Bob Elliot, reportedly commented: “Remarkably, a month after the first dose one patient is currently not dependent on insulin. While it is early days within this patient’s treatment protocol these results are very encouraging.”
He reportedly concluded: “These early stage results have exceeded our expectations.”